Giuseppe Curigliano

Overview

Best Publications

• Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

  A Goldhirsch;E P Winer;A S Coates;R D Gelber

  4118
  Citations

• 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

  F. Cardoso;A. Costa;E. Senkus;M. Aapro

  1832
  Citations

• Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

  Daniela Cardinale;Alessandro Colombo;Giulia Bacchiani;Ines Tedeschi

  1551
  Citations

• De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

  G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  1170
  Citations

• Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.

  Rashmi K Murthy;Sherene Loi;Alicia Okines;Elisavet Paplomata

  1054
  Citations

• Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

  G. Curigliano;D. Cardinale;T. Suter;G. Plataniotis

  951
  Citations

• Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

  Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  897
  Citations

• Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

  Giuseppe Curigliano;Daniel J. Lenihan;Michael G. Fradley;Sarju Ganatra

  810
  Citations

• Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

  Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  800
  Citations

• ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer†

  A. Gennari;F. André;C.H. Barrios;J. Cortés

  790
  Citations

• A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.

  Humaid O. Al-Shamsi;Waleed Alhazzani;Ahmad Alhuraiji;Eric A. Coomes

  722
  Citations

• Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

  Giuseppe Curigliano;Daniela Cardinale;Susan Dent;Carmen Criscitiello

  706
  Citations

• Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study.

  Sylvia Adams;Peter Schmid;Hope H.S. Rugo;Eric Winer

  678
  Citations

• Estimating the Benefits of Therapy for Early Stage Breast Cancer The St Gallen International Consensus Guidelines for the Primary Therapy of Early Breast Cancer 2019

  H.J. Burstein;G. Curigliano;S. Loibl;P. Dubsky

  574
  Citations

• Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.

  H J Burstein;G Curigliano;B Thürlimann;W P Weber

  566
  Citations

• HER2-Low Breast Cancer: Pathological and Clinical Landscape.

  Paolo Tarantino;Paolo Tarantino;Erika Hamilton;Sara M Tolaney;Javier Cortes

  529
  Citations

• Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

  M. V. Dieci;M. V. Dieci;C. Criscitiello;A. Goubar;G. Viale

  504
  Citations

• Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.

  Viviana Galimberti;Bernard F Cole;Giuseppe Viale;Giuseppe Viale;Paolo Veronesi;Paolo Veronesi

  482
  Citations

• Targeting the microenvironment in solid tumors.

  Carmen Belli;Dario Trapani;Giulia Viale;Paolo D'Amico

  461
  Citations

• Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28(8) (1700–1712), (S0923753419321817), (10.1093/annonc/mdx308))

  G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  38
  Citations